ENO1 promotes antitumor immunity by destabilizing PD-L1 in NSCLC
ENO1 promotes antitumor immunity by destabilizing PD-L1 in NSCLC
复制标题
ENO1 通过破坏 NSCLC 中 PD-L1 的稳定性来促进抗肿瘤免疫
DOI:
10.1038/s41423-021-00710-y
复制
发表时间:
2021
影响因子:
24.1
通讯作者:
D. Ge
中科院分区:
文献类型:
--
作者:
Chunyi Zhang;Kunpeng Zhang;Jie Gu;D. Ge
PD-L1 plays an important role in inhibiting T-cell activity and driving tumor cell escape from immune surveillance by binding its ligand, PD-1, on T cells. 1 Several intracellular and extracellular factors, such as interferon- γ (IFN- γ ), MYC, transforming growth factor β , and miR-200, may modulate PD-L1 expression by transcriptional and posttranscriptional mechanisms. 2 – 5 Here we discovered that ENO1, a novel protein, is involved in the regulation of PD-L1. ENO1 could destabilize PD-L1 and decrease its expression by promoting PD-L1 ubiquitination and subsequent proteasomal degradation in lung cancer cells. A lung cancer tissue microarray also showed that the expression of ENO1 was negatively correlated with PD-L1. Furthermore, overexpression of ENO1 sensitized tumor cells to speci fi c T-cell killing and increased T-cell-mediated antitumor immunity in syngeneic mouse models. In this study, we fi rst used immunoprecipitation coupled with mass spectrometry (IP-MS) to seek new regulators of PD-L1 expression. Coomassie blue staining of SDS-polyacrylamide gel electrophoresis revealed an ~50 kDa band in V5-bound immuno- precipitates (Supplementary Fig. S1) and MS identi fi ed a sequence consisting of ten consecutive amino acids from ENO1 in the band (Supplementary Fig. S2). A co-IP experiment proved that ENO1 interacted with PD-L1 in H1299 and SPC-A-1 cells with increased PD- L1 and ENO1 expression (Fig. 1A and Supplementary Fig. S3). Then, we detected whether ENO1 protein accumulation contributes to modulating
影响因子:
50.3
作者:
Lim SO;Li CW;Xia W;Cha JH;Chan LC;Wu Y;Chang SS;Lin WC;Hsu JM;Hsu YH;Kim T;Chang WC;Hsu JL;Yamaguchi H;Ding Q;Wang Y;Yang Y;Chen CH;Sahin AA;Yu D;Hortobagyi GN;Hung MC
通讯作者:
Hung MC